With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.

Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.

Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.

The Team

• An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
• Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
• Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)